Matthias Ernst

21.1k citations

220 papers · 15.2k indexed · 5 hit papers · h-index 68

Impact in

Immunology top 0.2%
- Immune Cell Function and Interaction
- Immune cells in cancer
- Immune Response and Inflammation
- T-cell and B-cell Immunology
- Psoriasis: Treatment and Pathogenesis
- IL-33, ST2, and ILC Pathways
Oncology top 0.2%
- Cytokine Signaling Pathways and Interactions

Papers in

Oncology 121
- Cytokine Signaling Pathways and Interactions 84
- Cancer Cells and Metastasis 14
Immunology 73
- Immune Cell Function and Interaction 16
- Immune cells in cancer 12
- IL-33, ST2, and ILC Pathways 12

Co-authors: Tracy L. Putoczki Ashleigh R. Poh Brendan J. Jenkins Gideon A. Rodan E. R. Froesch Joan K. Heath Dianne Grail Michael Büchert
Journals: Gastroenterology (9 papers)Cancer Research (8 papers)Cytokine (8 papers)Cancers (7 papers)The Journal of Immunology (7 papers)
Partner nations: Australia United States Germany

In The Last Decade

Matthias Ernst

213 papers receiving 15.0k citations

Hit Papers

5 papers align trajectories log scale

Targeting Macrophages in Cancer: From Bench to Bedside 2018 · 386 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2018 Frontiers in Oncology
2018 Nature reviews. Cancer
2009 Cancer Cell
2007 Nature Immunology
2006 Nature Immunology

Peers

Countries citing papers authored by Matthias Ernst

Since Specialization

Citations

This map shows the geographic impact of Matthias Ernst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Ernst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Ernst more than expected).

Fields of papers citing papers by Matthias Ernst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Ernst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Ernst. The network helps show where Matthias Ernst may publish in the future.

Co-authors

The 25 scholars most cited alongside Matthias Ernst, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Matthias Ernst Line = papers co-authored together Matthias Ernst links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Identification of Serum Biomarkers to Monitor Therapeutic Response in Intestinal-Type Gastric Cancer International Journal of Molecular Sciences ·Laura F. Dagley, Jumana Yousef, Adele Preaudet, Andrea Loving, Andrew I. Webb, Matthias Ernst, Tracy L. Putoczki	2024	1
2	Screening for Primary Aldosteronism by Mass Spectrometry Versus Immunoassay Measurements of Aldosterone: A Prospective Within-Patient Study The Journal of Applied Laboratory Medicine ·Sybille Fuld, Georgiana Constantinescu, Christina Pamporaki, Mirko Peitzsch, Manuel Schulze, Jun Yang, Lisa Müller, Aleksander Prejbisz, Andrzej Januszewicz, Hanna Remde, Lydia Kürzinger, Ulrich Dischinger, Matthias Ernst, Sven Gruber, Martín Reincke, Felix Beuschlein, Jacques W.M. Lenders, Graeme Eisenhofer	2024	5
3	A New Generation Automotive Tool Access Architecture for Remote in-Field Diagnosis SAE International Journal of Advances and Current Practices in Mobility ·Gašper Skvarč Božič, Ibai Irigoyen Ceberio, Matthias Ernst, Albrecht Mayer	2023	0
4	Improved glucose tolerance after initiation of Elexacaftor / Tezacaftor / Ivacaftor in adults with cystic fibrosis Journal of Cystic Fibrosis ·Carolin Steinack, Matthias Ernst, Felix Beuschlein, René Hage, Maurice Roeder, Macé M. Schuurmans, Christoph Schmid, Thomas Gaisl	2023	24
5	Combined Treatment with a WNT Inhibitor and the NSAID Sulindac Reduces Colon Adenoma Burden in Mice with Truncated APC Cancer Research Communications ·Maree C. Faux, Janet Weinstock, Sophia Gogos, Emma Prato, Alexander I. Azimpour, Ryan O’Keefe, Yasmin Cathcart‐King, Alexandra L. Garnham, Matthias Ernst, Adele Preaudet, Michael Christie, Tracy L. Putoczki, Michael Büchert, Antony W. Burgess	2022	7
6	EHF is essential for epidermal and colonic epithelial homeostasis, and suppresses Apc -initiated colonic tumorigenesis Development ·Camilla M. Reehorst, Rebecca Nightingale, Ian Y. Luk, Laura J. Jenkins, Frank Köentgen, David S. Williams, Charbel Darido, Fiona H. Tan, Holly Anderton, Michaël Chopin, Kael L. Schoffer, Moritz F. Eissmann, Michael Büchert, Dmitri Mouradov, Oliver M. Sieber, Matthias Ernst, Amardeep S. Dhillon, John M. Mariadason	2021	11
7	Rapid Resistance of FGFR-driven Gastric Cancers to Regorafenib and Targeted FGFR Inhibitors can be Overcome by Parallel Inhibition of MEK Molecular Cancer Therapeutics ·David K. Lau, Ian Y. Luk, Laura J. Jenkins, Andrew Martin, David S. Williams, Kael L. Schoffer, Fiona Chionh, Michael Büchert, Katrin Marie Sjoquist, Alex Boussioutas, Sarah A. Hayes, Matthias Ernst, Andrew Weickhardt, Nick Pavlakis, Niall C. Tebbutt, John M. Mariadason	2021	14
8	Development of a Multiplex Immunohistochemistry Workflow to Investigate the Immune Microenvironment in Mouse Models of Inflammatory Bowel Disease and Colon Cancer International Journal of Molecular Sciences ·Lokman Pang, Matthias Ernst, Jennifer Huynh	2021	3
9	STAT3 Signalling via the IL-6ST/gp130 Cytokine Receptor Promotes Epithelial Integrity and Intestinal Barrier Function during DSS-Induced Colitis Biomedicines ·Lokman Pang, Jennifer Huynh, Mariah Alorro, Xia Li, Matthias Ernst, Ashwini L. Chand	2021	19
10	Host IL11 Signaling Suppresses CD4+ T cell–Mediated Antitumor Responses to Colon Cancer in Mice Cancer Immunology Research ·Jennifer Huynh, David Baloyan, David Chisanga, Wei Shi, Megan A. O’Brien, Shoukat Afshar‐Sterle, Mariah Alorro, Lokman Pang, David S. Williams, Adam Parslow, Pathum Thilakasiri, Moritz F. Eissmann, Louis Boon, Frédérick Masson, Ashwini L. Chand, Matthias Ernst	2021	29
11	Frizzled-7 Is Required for Wnt Signaling in Gastric Tumors with and Without Apc Mutations Cancer Research ·Dustin J. Flanagan, Nick Barker, Natasha S. Di Costanzo, Elizabeth A. Mason, Austin Gurney, Valérie S. Méniel, Sarah Koushyar, Chloe R. Austin, Matthias Ernst, Helen Pearson, Alex Boussioutas, Hans Clevers, Toby J. Phesse, Elizabeth Vincan	2019	84
12	Repurposing the selective estrogen receptor modulator bazedoxifene to suppress gastrointestinal cancer growth EMBO Molecular Medicine ·Pathum Thilakasiri, Jennifer Huynh, Ashleigh R. Poh, Chin Wee Tan, Tracy L. Nero, Kelly Tran, Adam Parslow, Shoukat Afshar‐Sterle, David Baloyan, Natalie J. Hannan, Michael Büchert, Andrew M. Scott, Michael D. W. Griffin, Frédéric Hollande, Michael W. Parker, Tracy L. Putoczki, Matthias Ernst, Ashwini L. Chand	2019	36
13	Interleukin 33 Signaling Restrains Sporadic Colon Cancer in an Interferon-γ–Dependent Manner Cancer Immunology Research ·Moritz F. Eissmann, Christine D. Dijkstra, Merridee A. Wouters, David Baloyan, Dmitri Mouradov, Paul M. Nguyen, Mercedes Dávalos-Salas, Tracy L. Putoczki, Oliver M. Sieber, John M. Mariadason, Matthias Ernst, Frédérick Masson	2018	34
14	Inflammasome Adaptor ASC Suppresses Apoptosis of Gastric Cancer Cells by an IL18-Mediated Inflammation-Independent Mechanism Cancer Research ·Virginie Deswaerte, Paul M. Nguyen, Alison C. West, Alison F. Browning, Liang Yu, Saleela M. Ruwanpura, Jesse J. Balic, Thaleia Livis, Charlotte Girard, Adele Preaudet, Hiroko Oshima, Ka Yee Fung, Hazel Tye, Meri Najdovska, Matthias Ernst, Masanobu Oshima, Cem Gabay, Tracy L. Putoczki, Brendan J. Jenkins	2017	66
15	Smac mimetics and oncolytic viruses synergize in driving anticancer T-cell responses through complementary mechanisms Nature Communications ·Dae‐Sun Kim, Himika Dastidar, Chunfen Zhang, Franz J. Zemp, Keith C.K. Lau, Matthias Ernst, Andrea Rakic, Saif Sikdar, Jahanara Rajwani, Victor Naumenko, Dale R. Balce, Ben W. Ewanchuk, Pankaj Tailor, Robin M. Yates, Craig N. Jenne, Chris Gafuik, Douglas J. Mahoney	2017	53
16	Stomach-Specific Activation of Oncogenic KRAS and STAT3-Dependent Inflammation Cooperatively Promote Gastric Tumorigenesis in a Preclinical Model Cancer Research ·Stefan Thiem, Moritz F. Eissmann, Joachim Elzer, Anna Jonas, Tracy L. Putoczki, Ashleigh R. Poh, Paul M. Nguyen, Adele Preaudet, Dustin J. Flanagan, Elizabeth Vincan, Paul Waring, Michael Büchert, Andrew Jarnicki, Matthias Ernst	2016	34
17	Therapeutic Inhibition of Jak Activity Inhibits Progression of Gastrointestinal Tumors in Mice Molecular Cancer Therapeutics ·Emma Stuart, Michael Büchert, Tracy L. Putoczki, Stefan Thiem, Ryan Farid, Joachim Elzer, Dennis Huszar, Paul Waring, Toby J. Phesse, Matthias Ernst	2014	28
18	Genetic partitioning of interleukin‐6 signalling in mice dissociates Stat3 from Smad3‐mediated lung fibrosis EMBO Molecular Medicine ·Robert J.J. O’Donoghue, Darryl A. Knight, Carl D. Richards, Cecilia M. Prêle, Hui Ling Lau, Andrew Jarnicki, Jessica Jones, Steven Bozinovski, Ross Vlahos, Stefan Thiem, Brent S. McKenzie, Bo Wang, Philip A. Stumbles, Geoffrey J. Laurent, Robin J. McAnulty, Stefan Rose‐John, Hong‐Jian Zhu, Gary P. Anderson, Matthias Ernst, Steven E. Mutsaers	2012	128
19	Smad3 Dosage Determines Androgen Responsiveness and Sets the Pace of Postnatal Testis Development Endocrinology ·Catherine Itman, Chin Wong, B Hunyadi, Matthias Ernst, David A. Jans, Kate L. Loveland	2011	32
20	Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways Journal of Clinical Investigation ·Natalie A. Sims, Brendan J. Jenkins, J Quinn, Akira Nakamura, Markus Glatt, Matthew T. Gillespie, Matthias Ernst, T. John Martin	2004	151

About Matthias Ernst

Matthias Ernst is a scholar working on Oncology, Immunology, Cancer Research, Immunology and Allergy and Pharmacology, having authored 220 papers that have together received 15.2k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (84 papers), Helicobacter pylori-related gastroenterology studies (27 papers), Immune Cell Function and Interaction (16 papers), NF-κB Signaling Pathways (15 papers), Wnt/β-catenin signaling in development and cancer (14 papers), Cancer Cells and Metastasis (14 papers), Immune cells in cancer (12 papers) and IL-33, ST2, and ILC Pathways (12 papers). The work is most often cited by research in Immunology (5.6k citations), Oncology (5.7k citations), Cancer Research (2.0k citations), Molecular Biology (5.6k citations) and Pathology and Forensic Medicine (1.4k citations). Matthias Ernst has collaborated with scholars based in Australia, United States and Germany. Frequent co-authors include Tracy L. Putoczki, Ashleigh R. Poh, Brendan J. Jenkins, Gideon A. Rodan, E. R. Froesch, Joan K. Heath, Dianne Grail, Michael Büchert, Ashwini L. Chand and Jennifer Huynh. Their work appears in journals such as Gastroenterology, Cancer Research, Cytokine, Cancers and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact